Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Lentiviral Capsid-Mediated Cas9 Ribonucleoprotein Delivery for Efficient and Safe Multiplex Genome Editing

CRISPR J. 2021-03; 
Zuyan Lu, Xingang Yao, Pin Lyu, Manish Yadav, Kyung Yoo, Anthony Atala, Baisong Lu
Products/Services Used Details Operation
Gene Synthesis … 8,18 Plasmids will be made available through Addgene (IDs: 132553, 132555 and 136269) or on request. Gene synthesis was done by GenScript, Inc. All constructs generated were confirmed by Sanger sequencing. Sequence … Get A Quote

摘要

Transient expression of the CRISPR-Cas9 machinery is desirable to reduce the risks of off-targets and immune responses. Electroporation of Cas9 ribonucleoproteins (RNPs) is the most common delivery method to achieve transient Cas9 expression. Recently, retroviral capsids have been used for delivering Cas9 RNPs, in which Cas9 was fused to the viral proteins. The fusion strategy may cause relative low capsid assembly efficiency. We recently developed virus-like particles (VLPs) consisting of lentiviral capsid and Cas9 RNPs using the specific interactions between aptamer and aptamer-binding protein (ABP), and obtained near-normal capsid assembly efficiency. Here we test whether highly active Cas9 (SpCas9) RNP V... More

关键词

XML 地图